Cochrane · intervention · CD006968

Local interventions for the management of alveolar osteitis (dry socket)

Daly, BJM, Sharif, MO, Jones, K, et al. · Cochrane Database of Systematic Reviews · 2022 · Cochrane Library

Oral HealthOral and maxillofacial surgery3 versionsAMSTAR 2: not assessed
Full textEvery question was extracted from the full review (methods and results), not only its Summary of Findings table.
Questions
52
current version
GRADE rated
5
No studies
3
Included studies
49
as reported
No studies 3 · 5.8%Ungraded 44 · 84.6%Very low 2 · 3.8%Low 1 · 1.9%Moderate 2 · 3.8%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Review question

ElementPlanned (methods)Found (results)
PopulationAdults over 18 years who had undergone an extraction (routine or more complex surgical) of one or more permanent teeth under local anaesthesia (with or without sedation) or general anaesthesia, or who had developed dry socket post-extraction; smokers included; immunocompromised participants or those with comorbidities/medical conditions affecting oral healing excluded6771 participants across 49 trials; 39 prevention trials (6219 participants) and 10 treatment trials (552 participants); all but five studies involved extraction of third molars
InterventionAny type of local intervention used for the prevention or treatment of dry socket (antiseptic rinses, intrasocket gels/medicaments, tissue patches, autologous platelet concentrates, obtundent dressings); concomitant pain medication allowed if equal between groups; systemic antibiotics and surgical techniques excluded (covered by separate reviews)Chlorhexidine rinse 0.12%/0.2% (n=6); Chlorhexidine gel 0.2% (n=7); Chlorhexidine gel vs rinse (n=2); Platelet rich plasma (n=2); Honey (n=1); Gaseous ozone (n=1); Chlorhexidine monoject irrigation (n=1); Herbal mouthrinse (n=1); Tap water irrigation (n=1); Povidone iodine 1% (n=1); Oral tissue patch (n=1); Chlorhexidine gel 1% vs 0.2% (n=1); Acellular dermal matrix (n=2); Iodine tampon (n=1); Platelet rich fibrin (n=1); Bovine fibroblast growth factor (n=1); Metronidazole gel (n=1); Apernyl (n=1); Tranexamic acid (n=1); P-hydroxybenzoic acid (n=1); Heal-all tissue patch (n=1); Artemisia desertorum spreng Shahaosan/Yunnan (n=1); Zinc oxide eugenol/Alvogyl (n=2); Neocone (n=1); Topical anaesthetic gel (n=1); Plasma rich in growth factors PRGF (n=1); Advanced platelet rich fibrin (n=1); Metronidazole (n=1); Alvogyl vs SaliCept/no treatment (n=1); Alvogyl vs platelet rich fibrin (n=1)
ComparisonA different local intervention; placebo; or no treatmentPlacebo/no treatment; Chlorhexidine rinse; Chlorhexidine gel; Saline; Eugenol; Alvogyl; Zinc oxide eugenol; Control
OutcomesPrevention primary: proportion of participants presenting with a dry socket within 1 week post-treatment. Treatment primary: time to heal dry socket and socket healing indices; pain (severity and duration); swelling; limitation of chewing or swallowing; fever. Secondary: quality of life; patient satisfaction; costs. Adverse effects reported in a tablePresence of dry socket (n=39 prevention); Pain VAS (treatment; n=5+); Time to initial pain relief and complete resolution of pain (n=1); Duration of treatment (n=1); Healing (n=2); Exposed bone (n=1); Adverse events (tabulated)
Study designsRandomised controlled trials only (split-mouth/cross-over designs allowed for prevention)RCT (n=49)
TimingClinically important time points: at the end of the intervention and during follow-up of up to 2 weeksPrevention median 7 days follow-up; treatment pain assessed at 48 hours to day 7

Search date: 2021-09. Databases: Cochrane Oral Health's Trials Register; Cochrane Central Register of Controlled Trials (CENTRAL); MEDLINE Ovid; Embase Ovid; ClinicalTrials.gov; trial registries

Questions and results

Show all 3 versions

Chlorhexidine rinse (0.12% and 0.2%, pre- and post-extraction) vs Placebo or no treatment

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
2 questions
OutcomeEffectEvidenceStatus / GRADE
Adverse events
Follow-up: median 7 days
3 trials reported no adverse events. 1 study reported adverse events (alterations in taste, bad taste, staining) in 24/62 in chlorhexidine group versus 0/40 in placebo group, Peto OR = 8.42 (95% CI 3.31 to 21.39). A…6 studiesUngraded
Presence of dry socket
Follow-up: median 7 days
OR 0.38 [0.25, 0.58]
300 per 1000 (high); 50 per 1000 (moderate); 10 per 1000 (low) vs 140 per 1000
6 studies · 1547 participantsModerate
Downgraded: risk of bias

Chlorhexidine gel (0.2%, intrasocket) vs Placebo or no treatment

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
2 questions
OutcomeEffectEvidenceStatus / GRADE
Adverse events
Follow-up: median 7 days
No adverse events were reported. Six trials (673 participants) reported no adverse events from the use of chlorhexidine gel; one study (Rubio-Palau 2015) reported gastrointestinal discomfort (30, 18%), dizziness (10,…7 studiesUngraded
Presence of dry socket
Follow-up: median 7 days
OR 0.44 [0.27, 0.71]
300 per 1000 (high); 50 per 1000 (moderate); 10 per 1000 (low) vs 159 per 1000
7 studies · 753 participantsModerate
Downgraded: risk of bias

Chlorhexidine gel (0.2%, intrasocket) vs Chlorhexidine rinse (0.12%)

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
2 questions
OutcomeEffectEvidenceStatus / GRADE
Adverse events
Follow-up: median 7 days
No adverse events were reported in these two trials (Abu-Mostafa 2015; Hita-Iglesias 2008).2 studiesUngraded
Presence of dry socket
Follow-up: median 7 days
RR 0.74 [0.46, 1.20]
300 per 1000 (high); 50 per 1000 (moderate); 10 per 1000 (low) vs 222 per 1000
2 studies · 383 participantsLow
Downgraded: risk of bias, imprecision

Chlorhexidine rinse (0.2%) pre- and post-extraction vs Chlorhexidine rinse (0.2%) post-extraction only

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
1 question
OutcomeEffectEvidenceStatus / GRADE
Presence of dry socket
Follow-up: median 7 days
RR 0.58 [0.15, 2.17]1 study · 99 participantsUngraded

Acellular dermal matrix vs Control

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
2 questions
OutcomeEffectEvidenceStatus / GRADE
Presence of dry socket
Follow-up: median 7 days
RR 0.15 [0.04, 0.67]1 study · 300 participantsUngraded
Presence of dry socket
Follow-up: median 7 days
RR 0.07 [0.01, 0.50]1 study · 400 participantsUngraded

Glucocorticosteroid antibiotic agent (intrasocket) vs Normal saline

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
1 question
OutcomeEffectEvidenceStatus / GRADE
Presence of dry socket
Follow-up: median 7 days
OR (exact) 0 [0, 2.42]1 study · 19 participantsUngraded

Clindamycin phosphate antibiotic solution patch vs Saline patch

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
1 question
OutcomeEffectEvidenceStatus / GRADE
Presence of dry socket
Follow-up: median 7 days
OR (exact) 0 [0, 0.69]1 study · 86 participantsUngraded

Metronidazole gel (25%, intrasocket) vs Placebo gel

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
1 question
OutcomeEffectEvidenceStatus / GRADE
Presence of dry socket
Follow-up: median 7 days
RR 0.53 [0.23, 1.20]1 study · 302 participantsUngraded

Apernyl (acetylsalicylic acid pellet) vs Placebo

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
1 question
OutcomeEffectEvidenceStatus / GRADE
Presence of dry socket
Follow-up: median 7 days
RR 0.25 [0.03, 2.16]1 study · 100 participantsUngraded

Platelet rich plasma vs Placebo or no treatment

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
2 questions
OutcomeEffectEvidenceStatus / GRADE
Presence of dry socket
Follow-up: median 7 days
RR 0.51 [0.19, 1.33]
300 per 1000 (high); 50 per 1000 (moderate); 10 per 1000 (low) vs 153 per 1000
2 studies · 127 participantsVery low
Downgraded: risk of bias, imprecision
Adverse events
Follow-up: median 7 days
No adverse events were reported in these two trials.2 studiesUngraded

Tranexamic acid (AMCA cones) vs Placebo (lactose cones)

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
1 question
OutcomeEffectEvidenceStatus / GRADE
Presence of dry socket
Follow-up: median 7 days
RR 0.67 [0.30, 1.48]1 study · 120 participantsUngraded

P-hydroxybenzoic acid vs Placebo

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
1 question
OutcomeEffectEvidenceStatus / GRADE
Presence of dry socket
Follow-up: median 7 days
RR 0.08 [0.00, 1.37]1 study · 45 participantsUngraded

Heal-all tissue patch vs No treatment

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
1 question
OutcomeEffectEvidenceStatus / GRADE
Presence of dry socket
Follow-up: median 7 days
RR 0.08 [0.00, 1.32]1 study · 80 participantsUngraded

Artemisia desertorum spreng (Shahaosan) vs Placebo

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
1 question
OutcomeEffectEvidenceStatus / GRADE
Presence of dry socket
Follow-up: median 7 days
RR 0.13 [0.02, 1.02]1 study · 188 participantsUngraded

Artemisia desertorum spreng (Yunnan) vs Placebo

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
1 question
OutcomeEffectEvidenceStatus / GRADE
Presence of dry socket
Follow-up: median 7 days
RR 0.28 [0.06, 1.28]1 study · 182 participantsUngraded

Artemisia desertorum spreng (Shahaosan) vs Artemisia desertorum spreng (Yunnan)

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
1 question
OutcomeEffectEvidenceStatus / GRADE
Presence of dry socket
Follow-up: median 7 days
RR 0.47 [0.04, 5.06]1 study · 178 participantsUngraded

Topical anaesthetic gel (prilocaine-lidocaine) vs Eugenol

Population: Adults (>18 years) with established dry socket following permanent tooth extraction
1 question
OutcomeEffectEvidenceStatus / GRADE
Pain at 48 hours (VAS 0-10)
48 hours
MD -0.20 [-1.87, 1.47]1 study · 35 participantsUngraded

Metronidazole (intrasocket) vs Placebo

Population: Adults (>18 years) with established dry socket following permanent tooth extraction
1 question
OutcomeEffectEvidenceStatus / GRADE
Duration of treatment (days)
MD -3.17 [-5.30, -1.04]1 study · 55 participantsUngraded

Alvogyl vs No treatment

Population: Adults (>18 years) with established dry socket following permanent tooth extraction
1 question
OutcomeEffectEvidenceStatus / GRADE
Pain (VAS)
Alvogyl versus No treatment (Kaya 2011): data not usable (medians presented with error bars). Text reports differences in clinical signs and symptoms between control and all 3 treatment groups significant (P<0.05) at…1 studyUngraded

SaliCept (acemannan hydrogel) vs No treatment

Population: Adults (>18 years) with established dry socket following permanent tooth extraction
1 question
OutcomeEffectEvidenceStatus / GRADE
Pain (VAS)
SaliCept (acemannan hydrogel) versus No treatment (Kaya 2011): data not usable (medians presented with error bars). Text reports differences in clinical signs and symptoms between control and all 3 treatment groups…1 studyUngraded

Alvogyl vs SaliCept (acemannan hydrogel)

Population: Adults (>18 years) with established dry socket following permanent tooth extraction
1 question
OutcomeEffectEvidenceStatus / GRADE
Pain (VAS)
Alvogyl versus SaliCept (acemannan hydrogel) (Kaya 2011): data not usable (medians presented with error bars). Text reports differences in clinical signs and symptoms between control and all 3 treatment groups…1 studyUngraded

Honey (Manuka, topical) vs Chlorhexidine rinse (0.2%)

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
1 question
OutcomeEffectEvidenceStatus / GRADE
Presence of dry socket
Follow-up: median 7 days
RR 1.32 [0.41, 4.22]1 study · 100 participantsUngraded

Gaseous ozone vs Placebo or control

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
1 question
OutcomeEffectEvidenceStatus / GRADE
Presence of dry socket
Follow-up: median 7 days
RR 0.20 [0.02, 1.61]1 study · 60 participantsUngraded

Chlorhexidine 0.2% socket irrigation (monoject syringe) vs Chlorhexidine 0.2% mouthrinse

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
1 question
OutcomeEffectEvidenceStatus / GRADE
Presence of dry socket
Follow-up: median 7 days
RR 0.26 [0.09, 0.71]1 study · 95 participantsUngraded

Herbal mouthrinse vs Chlorhexidine 0.2% mouthrinse

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
1 question
OutcomeEffectEvidenceStatus / GRADE
Presence of dry socket
Follow-up: median 7 days
RR 0.50 [0.05, 5.17]1 study · 50 participantsUngraded

Tap water irrigation (monoject syringe) vs No rinsing

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
1 question
OutcomeEffectEvidenceStatus / GRADE
Presence of dry socket
Follow-up: median 7 days
RR 0.36 [0.18, 0.74]1 study · 336 participantsUngraded

Povidone iodine 1% vs Control

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
1 question
OutcomeEffectEvidenceStatus / GRADE
Presence of dry socket
Follow-up: median 7 days
RR 0.36 [0.14, 0.98]1 study · 189 participantsUngraded

Oral tissue patch vs Placebo or control

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
1 question
OutcomeEffectEvidenceStatus / GRADE
Presence of dry socket
Follow-up: median 7 days
RR 0.13 [0.02, 0.98]1 study · 200 participantsUngraded

Chlorhexidine gel 1% vs Chlorhexidine gel 0.2%

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
1 question
OutcomeEffectEvidenceStatus / GRADE
Presence of dry socket
Follow-up: median 7 days
RR 0.55 [0.15, 2.05]1 study · 88 participantsUngraded

Iodine tampon vs Saline irrigation (monoject syringe)

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
1 question
OutcomeEffectEvidenceStatus / GRADE
Presence of dry socket
Follow-up: median 7 days
Iodine tampon versus rinsing with saline in a syringe (Tuk 2019): Iodine tampon 0/54 Monoject with saline 0/54; no events (effect not estimable)1 study · 108 participantsUngraded

Platelet rich fibrin vs Control

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
1 question
OutcomeEffectEvidenceStatus / GRADE
Presence of dry socket
Follow-up: median 7 days
RR 0.44 [0.15, 1.35]1 study · 100 participantsUngraded

Recombinant bovine fibroblast growth factor gel vs Control

Population: Adults (>18 years) having permanent tooth extraction (predominantly mandibular third molars)
1 question
OutcomeEffectEvidenceStatus / GRADE
Presence of dry socket
Follow-up: median 7 days
RR 0.10 [0.01, 0.76]1 study · 160 participantsUngraded

Zinc oxide eugenol vs Alvogyl (old formulation)

Population: Adults (>18 years) with established dry socket following permanent tooth extraction
5 questions
OutcomeEffectEvidenceStatus / GRADE
Swelling
No studies reported this outcome0 studiesNo studies
Limitation of chewing or swallowing
No studies reported this outcome0 studiesNo studies
Healing
Healing: 2 studies (Faizel 2015; Supe 2018) used different healing outcomes and could not be combined; Alvogyl appeared to heal faster than zinc oxide eugenol. Supe 2018: delayed (non-healed after 10 days) 2/25 Alvogyl…2 studiesUngraded
Pain (VAS 0-10)
Day 7
MD 1.40 [1.04, 1.75]
Alvogyl: median 1.7 (VAS 0-10) vs Zinc oxide eugenol: 1.04 higher to 1.75 higher
2 studies · 80 participantsVery low
Downgraded: risk of bias, inconsistency
Fever
No studies reported this outcome0 studiesNo studies

Neocone vs Alvogyl

Population: Adults (>18 years) with established dry socket following permanent tooth extraction
2 questions
OutcomeEffectEvidenceStatus / GRADE
Time to initial pain relief (minutes)
Initial pain relief
MD 9.87 [9.12, 10.63]1 study · 78 participantsUngraded
Time to complete resolution of pain (days)
Complete resolution of pain
MD -1.62 [-1.86, -1.38]1 study · 78 participantsUngraded

Neocone vs Zinc oxide eugenol

Population: Adults (>18 years) with established dry socket following permanent tooth extraction
2 questions
OutcomeEffectEvidenceStatus / GRADE
Time to complete resolution of pain (days)
Complete resolution of pain
MD -3.79 [-4.04, -3.54]1 study · 78 participantsUngraded
Time to initial pain relief (minutes)
Initial pain relief
MD -7.77 [-8.86, -6.68]1 study · 78 participantsUngraded

Alvogyl vs Zinc oxide eugenol

Population: Adults (>18 years) with established dry socket following permanent tooth extraction
2 questions
OutcomeEffectEvidenceStatus / GRADE
Time to complete resolution of pain (days)
Complete resolution of pain
MD -2.17 [-2.37, -1.97]1 study · 78 participantsUngraded
Time to initial pain relief (minutes)
Initial pain relief
MD -17.64 [-18.76, -16.52]1 study · 78 participantsUngraded

Plasma rich in growth factors (PRGF) vs Alvogyl

Population: Adults (>18 years) with established dry socket following permanent tooth extraction
2 questions
OutcomeEffectEvidenceStatus / GRADE
Exposed bone (present versus absent)
Day 7 (also day 3)
PRGF versus Alvogyl (King 2018), exposed bone (% patients): day 3 PRGF 9.1% vs Alvogyl 9.1%; day 7 PRGF 0% vs Alvogyl 22.7% (P<0.05 at day 7)
Alvogyl: 22.7% (day 7); 9.1% (day 3) vs PRGF: 0% (day 7); 9.1% (day 3)
1 study · 44 participantsUngraded
Pain (VAS cm)
Day 7 (also day 3)
MD -0.40 [-1.77, 0.97]1 study · 44 participantsUngraded

Advanced platelet rich fibrin (A-PRF) vs Control (no treatment)

Population: Adults (>18 years) with established dry socket following permanent tooth extraction
1 question
OutcomeEffectEvidenceStatus / GRADE
Pain (VAS cm)
Days 1-7 (day 7 shown)
MD -3.60 [-4.00, -3.20]1 study · 40 participantsUngraded

Alvogyl vs Platelet rich fibrin

Population: Adults (>18 years) with established dry socket following permanent tooth extraction
1 question
OutcomeEffectEvidenceStatus / GRADE
Pain
Alvogyl versus platelet rich fibrin (Keshini 2020): single study (30 participants); no usable pooled estimate extracted1 study · 30 participantsUngraded